Etoposide-loaded biodegradable amphiphilic methoxy (poly ethylene glycol) and poly (epsilon caprolactone) copolymeric micelles as drug delivery vehicle for cancer therapy

Drug Delivery

Volumn 17, Issue 5, 2010, Pages 330-342

  Mohanty, Anjan K ^a   Dilnawaz, Fahima ^a   Mohanty, Chandana ^a   Sahoo, Sanjeeb K ^a  

^a INSTITUTE OF LIFE SCIENCES   (India)

Author keywords

Cancer; Diblock copolymers; Drug delivery; Etoposide; Micelles

Indexed keywords

ETOPOSIDE; MACROGOL; POLYCAPROLACTONE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOTOXICITY; DRUG DELIVERY SYSTEM; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRUG RELEASE; ENCAPSULATION; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; MICELLE; MICELLIZATION; MOLECULAR WEIGHT; PANCREAS CANCER; PARTICLE SIZE; PRIORITY JOURNAL; RING OPENING;

ANTINEOPLASTIC AGENTS, PHYTOGENIC; CALORIMETRY, DIFFERENTIAL SCANNING; CELL LINE, TUMOR; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CRYSTALLIZATION; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; ETOPOSIDE; HUMANS; INHIBITORY CONCENTRATION 50; MICELLES; MOLECULAR WEIGHT; PANCREATIC NEOPLASMS; PARTICLE SIZE; POLYESTERS; POLYETHYLENE GLYCOLS;

EID: 77953278223     PISSN: 10717544     EISSN: 15210464     Source Type: Journal    
DOI: 10.3109/10717541003720688     Document Type: Article

References (58)

1. Abe, T., Hasegawa, S., Taniguchi, K., Yokomizo, A., Kuwano, T., Ono, M., Mori, T., Hori, S., Kohno, K., Kuwano, M. (1994). Possible involvement of multidrug-resistance-associated protein (MRP) gene expression in spontaneous drug resistance to vincristine, etoposide and adriamycin in human glioma cells. Int J Cancer. 58:860-864.
2. Adams, M.L., Lavasanifar, A., Kwon, G.S. (2003). Amphiphilic block copolymers for drug delivery. J Pharm Sci. 92:1343-55.
3. Aliabadi, H.M., Shahin, M., Brocks, D.R., Lavasanifar, A. (2008). Disposition of drugs in block copolymer micelle delivery systems: from discovery to recovery. Clin Pharmacokinet. 47:619-634
4. Astafieva, I., Zhong, X.F., Eisenberg, A. (1993). Critical micellization phenomena in block polyelectrolyte solution. Macromolecules. 26:7339-7352
5. Becher, P., Schick, M. (1987). Nonionic surfactants physical chemistry. Marcel Dekker, New York..
6. Bisht, S., Feldmann, G., Soni, S., Ravi, R., Karikar, C., Maitra, A., Maitra, A. (2007). Polymeric nanoparticle-encapsulated curcumin ('nanocurcumin'): a novel strategy for human cancer therapy. J Nanobiotechnol. 5:1-18.
7. Chasin, M., Langer, R. (1990). Biodegradable polymers as drug delivery systems. USA: Marcel Dekker.
8. Danson, S.,Ferry, D., Alakhov, V., Margison, J., Kerr, D., Jowle, D., Brampton, M., Halbert, G., Ranson, M. (2004). Phase I dose escalation and pharmacokinetic study of pluronic polymer-bound doxorubicin (SP1049C) in patients with advanced cancer. Br J Cancer. 90:2085-2091
9. Dezhu, M., Xiaolie, L., Ruiyun, Z., Nishi, T. (1996). Miscibility and spherulites in blends of poly(e-caprolactone) with ethylene terephthalate- caprolactone copolyester. Polymer. 37:1575-1581
10. Elamanchili, P., McEachern, C., Burt, H. (2008). Reversal of multidrug resistance by methoxypolyethylene glycol-block-polycaprolactone diblock copolymers through the inhibition of P-glycoprotein function. J Pharm Sci. 98:945-958
11. Gao, Z., Eisenberg, A. (1993). A model micellization for block copolymers in solutions. Macromolecules. 26:7353-7360
12. Gref, R., Mainamitake, Y., Peracchia, M.T., Langer, R. (1996). Microparticulate systems for the delivery of protein and vaccines. USA: Marcel Dekker, New York.
13. Gros, L., Delaporte, C., Frey, S., Decesse, J., de Saint-Vincent, B. R., Cavarec, L., Dubart, A., Gudkov, A.V., Jacquemin-Sablon, A. (2003). Identification of new drug sensitivity genes using genetic suppressor elements: protein arginine N-methyltransferase mediates cell sensitivity to DNA-damaging agents. Cancer Res. 63:164-171
14. Huatan, H., Collett, J.H., Attwood, D. (1995). The microencapsulation of protein using a novel ternary blend based on poly(epsiloncaprolactone). J Microencapsul. 12:557-567
15. Iyer, A.K., Khaled, G., Fang, J., Maeda, H. (2005). Exploiting the enhanced permeability and retention effect for tumor targeting. Drug Discov Today. 2006, 17-18:812-818
16. Kakizawa, Y., Kataoka, K. (2002). Block copolymer micelles for delivery of gene and related compounds. Adv Drug Deliv Rev. 54:203-222
17. Kalanasundaram, K., Thomas, J.K. (1977). Environmental effects on vibronic band intensities in pyrene monomer fluorescence and their application in studies of micellar systems. J Am Chem Soc. 99:2039-2044
18. Kataoka, K., Harada, A., Nagasaki, Y. (2001). Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Deliv Rev. 47:113-131
19. Kataoka, K., Kwon, G.S. (1993). Block copolymer micelles as vehicles for drug delivery. J Cont Rel. 24:119-132
20. Kim, S.Y., Shin, I.G., Lee, Y.M., Cho, C.S., Sung, Y.K. (1998). Methoxy poly(ethylene glycol) and epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. II. Micelle formation and drug release behaviours. J Contr Rel. 51:13-22.
21. Kim, S.Y., Lee, Y.M. (2001). Taxol-loaded block copolymer nanospheres composed of methoxy poly(ethylene glycol) and poly(epsiloncaprolactone) as novel anticancer drug carriers. Biomaterials. 22:1697-1704
22. Koike, K., Abe, T., Hisano, T., Kubo, T., Wada, M., Kohno, K., Kuwano, M. (1996). Overexpression of multidrug resistance protein gene in humane cancer cell lines selected for drug resistance to epipodophyllotoxin. Jpn J Cancer Res. 87:765-772.
23. Kotze, A.F., de Leeuw, BJ., Lueben, HL., de Boer, AG., Verhoef, JC., Junginger, HE. (1997). Chitosans for enhanced delivery of therapeutics peptides across intestinal epithalia: in vitro evaluation in Caco-2 cell monolayers. Int J Pharm. 159:243-253
24. Kwon, G.S., Kataoka, K. (1995). Block copolymer micelles as long circulating drug vehicles. Adv Drug Deliv Rev. 16: 295-309.
25. La, S.B., Okano, T., Kataoka, K. (1996). Preparation and characterization of the micelle-forming polymeric drug indomethacin-incorporated poly(ethylene oxide)-poly(beta-benzyl L-aspartate) block copolymer micelles. J Pharm Sci. 85:85-90.
26. Lampretch, A., Benoit, J.-P. (2006). Etoposide nanocarriers suppress glioma cell growth by intracellular drug delivery and simultaneous P-glycoprotein inhibition. J Contr Rel. 112:208-213
27. Lee, J.S., Hwang, S.J., Lee, D.S., Kim, S.C., Kim, D.W. (2009). Formation of poly(ethylene glycol)-poly(ε-caprolactone) nanoparticles via nanoprecipitation. Macromol Res. 17:72-78
28. Maeda, H., Wu, J., Sawa, T., Matsumura, Y., Hori, K. (2000). Tumour vascular permeability and the EPR effect in macromolecular therapeutics: a review. J Contr Rel. 65:271-284
29. Matsumura, Y., Hamaguchi, T., Ura, T., Muro, K., Yamada, Y., Shimada, Y., Shirao, K., Okusaka, T., Ueno, H., Ikeda, M., Watanabe, N. (2004). Phase I clinical trial and pharmacokinetic evaluation of NK911, a micelle-encapsulated doxorubicin. Br J Cancer. 91:1775-1781
30. Mikhail, S., Allen, C. (2009). Block copolymer micelles for delivery of cancer therapy: transport at the whole body, tissue and cellular levels. J Contr Rel. 138:214-223
31. Oh, K.T., Bronich, T K., Bromberg, L., Alan, H,T., Kabanov, A V. (2006). Block ionomer complexes as prospective nanocontainers for drug delivery. J Contr Rel. 115:9-17.
32. Park, E.K., Kim, S.Y., Lee, S.B., Lee, Y.M. (2005). Folate-conjugated methoxy poly(ethylene glycol)/poly(epsilon-caprolactone) amphiphilic block copolymeric micelles for tumour-targeted drug delivery. J Contr Rel. 109:158-168
33. Peter, J., Ester, M., Peter, V., Jennie, H., Peter, J., Jan, F. (1997). Melt block copolymerisation of e-caprolactone and lactide. J Polym Sci A. 35:219-226
34. Raju, Y.P., Garbhapu, A., Prasanna, S.A.L., Rao, B.S., Murthy, R. (2007). Studies on enhancement of dissolution rate of etoposide. Indian J Pharm Sci. 69:269-273
35. Reddy, L.H., Adhikari, J S., Dwarakanath, B.S.R., Sharma,R K., Murthy, R.R. (2006). Tumouricidal effects of etoposide incorporated into solid lipid nanoparticles after intraperitoneal administration in dalton's lymphoma bearing mice. AAPS J. 8:E254-62.
36. Sahoo, S.K., Ma, W., Labhasetwar, V. (2004). Efficacy of a transferrinconjugated paclitaxel loaded nanoparticles in a murine model of prostate cancer. Int J Cancer. 112:335-340
37. Salido, M., Gonzalez, J., Vilches, J. (2007). Loss of mitochondrial membrane potential is inhibited by bombesin in etoposide-induced apoptosis in PC-3 prostate carcinoma cells. Mol Cancer Ther. 6:1292-1299
38. Sato, N., Mizumoto, K., Kusumoto, M., Nishio, S., Maehara, N., Urashima, T., Ogawa, T., Tanaka, M. (2000). Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide. Br J Cancer. 82:1819-1826
39. Scholz, G., Lijima, M., Nagasaki, Y., Kataoka, K. (1995). A novel reactive polymeric micelle with aldehyde groups on its surface. Macromolecules. 28:7295-7297
40. Sengupta, S., Velpandian, T., Sapra, P., Sanyal, M., Gupta, S.K. (1998). Etoposide encapsulated long circulating liposomes: improved antitumour efficacy with reduced adverse effects. Naunyn Schmeideberg's Arch Pharmacol. 358:R531.
41. Sengupta, S., Tyagi, P., Velpandian, T., Gupta, Y.K., Gupta, S.K. (2000). Etoposide encapsulated in positively charged liposomes: pharmacokinetic studies in mice and formulation stability studies. Pharmacol Res. 42:459-464
42. Shi, B., Fang, C., You, XM., Zhang, Y., Fu, S., Pei, YY. (2005). Stealth MePEG-PCL micelles: effects of polymer composition on micelle physicochemical characteristics, in vivo drug release, in vivo pharmacokinetics in rats and biodistribution in S180 tumour bearing mice. Colloid Polym Sci. 283:954-967
43. Shin, H.-C., Alani, A.W.G., Rao, D.A., Rockich, N.C., Kwon, G.S. (2009). Multi-drug loaded polymeric micelles for simultaneous delivery of poorly soluble anticancer drugs. J Contr Rel. 140:294-300.
44. Shin, I.G., Kim, S.Y., Lee, Y.M., Cho, C.S., Sung, Y.K. (1998b). Methoxy poly(ethylene glycol)/epsilon-caprolactone amphiphilic block copolymeric micelle containing indomethacin. I. Preparation and characterization. J Contr Rel. 51:1-11.
45. Shirazi, F.H., Bahrami, G., Stewart, D.J., Tomiak, E., Delorme, F., Noel, D., Goel, R. (2001). A rapid reversed phase high performance liquid chromatographic method for determination of etoposide (VP-16) in human plasma. J Pharm Biomed Anal. 25:353-356
46. Shuai, X., Ai, H., Nasongkla, N., Kim, S., Gao, J. (2004). Micellar carriers based on block copolymers of poly(epsilon-caprolactone) and poly(ethylene glycol) for doxorubicin delivery. J Contr Rel. 98:415-426
47. Smit, E.F., Carney, D.N., Hurford, P., Sleijfer, D.T., Postmos, P.E. (1989). Phase II study oral etoposide in elderly patients with small cell lung cancer. Thorax. 44:631-633
48. Snehalatha, M., Venugopal, K., Saha, R.N., Babbar, A.K., Sharma, R.K. (2008). Etoposide loaded PLGA and PCL nanoparticles II: biodistribution and pharmacokinetics after radiolabeling with Tc-99m. Drug Deliv. 15:277-287
49. Sutton, D., Nasongkla, N., Blanco, E., Gao, J. (2007). Functionalized micellar systems for cancer targeted drug delivery. Pharm Res. 24:1029-1046
50. Tang, B.C., Fu, J., Watkins, D.N., Hanes, J. (2010). Enhanced efficacy of local etoposide delivery by poly(ether-anhydride) particles against small cell lung cancer in vivo. Biomaterials. 31:339-344
51. Torchilin, V.P. (2007). Micellar nanocarriers: pharmaceutical perspectives. Pharm Res. 24:1-16.
52. Tyagi, P., Sengupta, S., Velpandian, T., Gupta, Y.K., Kochupillai, V., Gupta, S.K. (1999). Evaluations of the antitumour activity of liposomal formulations of etoposide against choriocarcinoma xenograft in Balb/c nu/nu mice. Pharm Pharmacol Commun. 5:595-598
53. Wang, F., Bronich, T.K., Kabanov, A.V., Rauh, R.D., Roovers, J. (2005). Synthesis and evaluation of a star amphiphilic block copolymer from poly(epsilon-caprolactone) and poly(ethylene glycol) as a potential drug delivery carrier. Bioconjug Chem. 16:397-405.
54. Whitesides, G.M., Mathias, J.P., Seto, C.T. (1991). Molecular self-assembly and nanochemistry: a chemical strategy for the synthesis of nanostructures. Science. 254:1312-1319
55. Yekta, A., Duhamel, J., Brochard, P., Adiwidjja, H., Winnik, M.A. (1993). A fluorescenct probe study of hydrophobically modified poly (ethylene oxide). Macromolecules. 26: 1829-1836
56. Zhou, S., Deng, X., Yang, H. (2003). Biodegradable poly(epsiloncaprolactone)-poly(ethylene glycol) block copolymers: characterization and their use as drug carriers for a controlled delivery system. Biomaterials. 24:3563-3570
57. Zhu, J., Jiang, W. (2007). Self assembly of block copolymers in selective solvents. In: Chemical physics research trend. Vol.252, Chapter 2. Sameul V Arnold (Ed) Nova Science publishers, Inc, New York:65-116.
58. Zhu, Z., X., Xiong, C.D., Zhang, L.L., Deng, X. (1997). Synthesis and characterisation of poly(e-caprolactone)-poly(ethylene glycol) block copolymer. J Polym Sci A. 35:709-714